Poland· PL-100229917
Sycrest
A asenapine product containing asenapinum, registered in Poland by N.V. Organon. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Asenapine is registered in 14 of 19 countries.
Countries holding a registration under ATC N05AH05 (asenapine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Asenapine · ATC N05AH05
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of asenapine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Asenapine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$10.74
- IT Italy$8.14
The record
At a glance
URPL (Poland)- Active substance
- Asenapinum
- Manufacturer
- N.V. Organon
- Country
- Poland (PL)
- ATC code
- N05AH05
- ATC class
- Asenapine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990792160
- gtin05909990792177
- gtin05909990792184
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
317 interactions on record for asenapine.
Graded by severity as the source publishes them — 46 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Asenapine · interactions on record
317 records
- 46 severe
- 264 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Asenapine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAsenapineAlembic Pharmaceuticals Limited
- SpainSYCREST 10 MG COMPRIMIDOS SUBLINGUALESOrganon N.V.
- CzechiaSYCRESTN.V. Organon, Oss
- United KingdomAsenapine 10mg sublingual tablets sugar freeImported
- BelgiumSycrest 10 mgOrganon
- IrelandSycrest 10 mg sublingual tabletsNV Organon
- IcelandSycrestN.V. Organon
- NetherlandsSycrest 10 mg, tablet voor sublinguaal gebruikN.V. Organon (Kloosterstraat 6)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Sycrest
- Liechtenstein · Sycrest
- Norway · Sycrest
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/004e84fe-7d0d-4c84-a8fd-793f66c981c4 GET /v1/drugs/004e84fe-7d0d-4c84-a8fd-793f66c981c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki podjęzykowe",
"source": "urpl",
"strength": "10 mg",
"packaging": "05909990792160 ¦ Rp ¦ EU/1/10/640/004 ¦ 59324\n20 tabl.\n05909990792177 ¦ Rp ¦ EU/1/10/640/005 ¦ 59325\n60 tabl.\n05909990792184 ¦ Rp ¦ EU/1/10/640/006 ¦ 59326\n100 tabl.",
"substance": "Asenapinum 10 mg",
"common_name": "Asenapinum",
"pl_product_id": "100229917",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about asenapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.